Open Access
Translator Disclaimer
May 2000 Clinical Trials and Sample Size Considerations: Another Perspective
Sandra J. Lee, Marvin Zelen
Statist. Sci. 15(2): 95-110 (May 2000). DOI: 10.1214/ss/1009212752

Abstract

We propose a Bayesian formulation of the sample size problem for planning clinical trials. The frequentist paradigm for calculating sample sizes for clinical trials is to prespecify the type I and II error probabilities. These error probabilities are conditional on the true hypotheses. Instead we propose prespecifying posterior probabilities which are conditional on the outcome of the trial. Our method is easy to implement and has intuitive interpretations. We illustrate an application of our method to the planning of cancer clinical trials for the Eastern Cooperative Oncology Group (ECOG).

Citation

Download Citation

Sandra J. Lee. Marvin Zelen. "Clinical Trials and Sample Size Considerations: Another Perspective." Statist. Sci. 15 (2) 95 - 110, May 2000. https://doi.org/10.1214/ss/1009212752

Information

Published: May 2000
First available in Project Euclid: 24 December 2001

Digital Object Identifier: 10.1214/ss/1009212752

Rights: Copyright © 2000 Institute of Mathematical Statistics

JOURNAL ARTICLE
16 PAGES


SHARE
Vol.15 • No. 2 • May 2000
Back to Top